Abeona Therapeutics
ABEO
39 hedge funds and large institutions have $41.6M invested in Abeona Therapeutics in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 9 closing their positions.
164% more capital invested
Capital invested by funds: $15.8M → $41.6M (+$25.9M)
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
5% more funds holding
Funds holding: 37 → 39 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.31M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$1.04M |
| 3 |
NC
Nexthera Capital
New York
|
+$867K |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$398K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$391K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$1.67M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$637K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$429K |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$326K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$99K |
ABEO Hedge Fund Activity: Q3 2016 in Review
39 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2016, worth a combined $41.6M — up 164% from $15.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ABEO positions and 9 closed out — a net gain of 2 holders — while 11 added to existing stakes and 6 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.31M. The largest seller was Perceptive Advisors, cutting an estimated $1.67M.
- 39 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2016, up from 37 in Q2 2016.
- Funds reported $41.6M of Abeona Therapeutics stock for Q3 2016, up 164% quarter-over-quarter.
- 11 funds opened new Abeona Therapeutics positions in Q3 2016 and 9 closed out, a net change of +2 holders.
- The largest Abeona Therapeutics buyer in Q3 2016 was Millennium Management, an estimated $1.31M added.
- The largest Abeona Therapeutics seller in Q3 2016 was Perceptive Advisors, an estimated $1.67M sold.
Based on aggregated 13F filings for Q3 2016.